Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease

Patients with autoimmune disease (AD) are at increased risk for complications from COVID-19 infection, so, optimizing vaccine utilization in this population is of particular importance. We compared COVID-19 vaccination perspectives among persons with and without AD. 471 patients in the MetroHealth S...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2024-04, Vol.42 (12), p.2994-3001
Main Authors: Gong, Jenny D., Barnboym, Emma, O'Mara, Megan, Gurevich, Natalie, Mattar, Maya, Anthony, Donald D., Perzynski, Adam T., Singer, Nora G.
Format: Article
Language:English
Subjects:
Arthritis
Autoimmune disease
Autoimmune diseases
Autoimmune Diseases - complications
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccine
COVID-19 Vaccines
Demographics
Health care facilities
Humans
Infections
Least squares method
Pandemics
Patients
Population
Regression analysis
Regression models
Safety
Self Report
Statistical power
Vaccination
Vaccine hesitancy
Vaccines
Variables
Viral diseases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with autoimmune disease (AD) are at increased risk for complications from COVID-19 infection, so, optimizing vaccine utilization in this population is of particular importance. We compared COVID-19 vaccination perspectives among persons with and without AD. 471 patients in the MetroHealth System and Cleveland Veteran Affairs Medical Center completed a 38-item questionnaire between August 2021 and February 2022. This survey containing questions regarding COVID-19 vaccine perceptions and demographics was administered both to unvaccinated individuals and individuals who delayed vaccination for at least 2 months. Multivariable ordinary least squares regression models were created to assess factors associated with vaccination likelihood. The number of reasons given for (p 
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2024.03.067